CRL
Charles River Laboratories International, Inc.
Stock
$290.19+3.36 (+1.17%)Close Oct 2, 2026
Income statement
| Line | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.0B | $4.0B | $4.0B | $4.1B | $4.0B | $3.5B | $2.9B | $2.6B | $2.3B | $1.9B | $1.7B | $1.4B | $1.3B | $1.2B | $1.1B | $1.1B | $1.1B | $1.2B | $1.3B |
| Cost of revenue | — | — | — | — | — | — | — | — | — | $290M | $277M | $264M | $266M | $273M | $258M | $268M | $253M | $256M | $253M |
| Gross profit | — | — | — | — | — | — | — | — | — | $1.6B | $1.4B | $1.1B | $1.0B | $893M | $872M | $875M | $880M | $916M | $1.0B |
| SG&A | $762M | $743M | $751M | $748M | $665M | $620M | $529M | $518M | $444M | $371M | $365M | $300M | $269M | $226M | $208M | $199M | $232M | $228M | $224M |
| Other operating expenses | — | — | — | — | — | — | — | — | — | $908M | $802M | $592M | $585M | $516M | $498M | $502M | $946M | $519M | $1.3B |
| Operating income | $90M | $25M | $227M | $617M | $651M | $590M | $433M | $351M | $331M | $288M | $238M | $206M | $178M | $151M | $166M | $174M | −$299M | $170M | −$452M |
| Non-operating income | — | −$125M | −$134M | −$36M | −$28M | −$109M | $14M | −$47M | −$50M | $8.7M | −$15M | −$11M | −$75K | −$13M | −$36M | −$42M | −$36M | −$18M | −$20M |
| Pretax income | — | −$100M | $93M | $581M | $623M | $481M | $447M | $304M | $282M | $297M | $223M | $195M | $178M | $138M | $130M | $133M | −$334M | $152M | −$471M |
| Taxes | — | $45M | $71M | $107M | $137M | $90M | $83M | $52M | $55M | $174M | $68M | $46M | $51M | $35M | $32M | $23M | $2.6M | $37M | $53M |
| Net income | −$238M | −$144M | $22M | $475M | $486M | $391M | $364M | $252M | $226M | $123M | $155M | $149M | $127M | $103M | $97M | $110M | −$337M | $114M | −$525M |
| Diluted EPS | −$4.91 | −$2.91 | $0.20 | $9.22 | $9.48 | $7.60 | $7.20 | $5.07 | $4.62 | $2.54 | $3.23 | $3.13 | $2.66 | $2.12 | $2.01 | $2.14 | −$5.38 | $1.74 | −$7.80 |
| Diluted shares | — | 49.6M | 51.6M | 51.5M | 51.3M | 51.4M | 50.6M | 49.7M | 49.0M | 48.6M | 48.0M | 47.6M | 47.6M | 48.5M | 48.4M | 51.3M | 62.6M | 65.6M | — |
| Revenue growth | — | −0.9% | −1.9% | +3.9% | +12.3% | +21.1% | +11.5% | +15.7% | +22.0% | +10.5% | +23.3% | +5.1% | +11.3% | +3.2% | −1.1% | +0.8% | −3.3% | −9.5% | — |
| Gross margin | — | — | — | — | — | — | — | — | — | 84.4% | 83.5% | 80.6% | 79.5% | 76.6% | 77.2% | 76.5% | 77.7% | 78.2% | 80.5% |
| Operating margin | 2.3% | 0.6% | 5.6% | 14.9% | 16.4% | 16.7% | 14.8% | 13.4% | 14.6% | 15.5% | 14.1% | 15.1% | 13.7% | 13.0% | 14.7% | 15.3% | −26.3% | 14.5% | −34.9% |
| Net margin | −6.0% | −3.6% | 0.5% | 11.5% | 12.2% | 11.0% | 12.5% | 9.6% | 10.0% | 6.6% | 9.2% | 11.0% | 9.8% | 8.8% | 8.6% | 9.6% | −29.7% | 9.8% | −40.5% |